Hypersensibilité au budésonide = Hypersensitivity to budesonideLE COZ, C.-J.Annales de dermatologie et de vénéréologie. 2002, Vol 129, Num 12, pp 1409-1410, issn 0151-9638, 2 p.Article

In vitro determination of inhaled mass and particle distribution for budesonide nebulizing suspensionSMALDONE, G. C; CRUZ-RIVERA, M; NIKANDER, K et al.Journal of aerosol medicine. 1998, Vol 11, Num 2, pp 113-125, issn 0894-2684Article

The use of atomic force microscopy to study the conditioning of micronised budesonideJONES, Matthew D; YOUNG, Paul M; TRAINI, Daniela et al.International journal of pharmaceutics. 2008, Vol 357, Num 1-2, pp 314-317, issn 0378-5173, 4 p.Article

Effect of formoterol/budesonide combination on arterial blood gases in patients with acute exacerbation of COPDCAZZOLA, M; NOSCHESE, P; DE MICHELE, F et al.Respiratory medicine. 2006, Vol 100, Num 2, pp 212-217, issn 0954-6111, 6 p.Article

Preparation of budesonide/γ-cyclodextrin complexes in supercritical fluids with a novel SEDS methodTOROPAINEN, Tarja; VELAGA, Sitaram; HEIKKILÄ, Teemu et al.Journal of pharmaceutical sciences. 2006, Vol 95, Num 10, pp 2235-2245, issn 0022-3549, 11 p.Article

Safety profile of budesonide inhalation suspension in the pediatric population: worldwide experienceSZEFLER, Stanley J; LYZELL, Ewa; FITZPATRICK, Sherahe et al.Annals of allergy, asthma, & immunology. 2004, Vol 93, Num 1, pp 83-90, issn 1081-1206, 8 p.Article

Initial loading (400 μg twice daily) versus static (400 μg nocte) dose budesonide for asthma managementCAMPBELL, L. M; GOODING, T. N; AITCHISON, W. R. C et al.International journal of clinical practice (Esher). 1998, Vol 52, Num 6, pp 361-370, issn 1368-5031, 8 p.Article

Contact allergy to budesonide and perforation of the nasal septumISAKSSON, M; BRUZE, M; WIHL, J.-A et al.Contact dermatitis. 1997, Vol 37, Num 3, issn 0105-1873, p. 133Article

Suppression of intestinal mucosal natural killer cells by corticosteroidsVAN IERSSEL, A. J. H. M; MIEREMET-OOMS, M. A. C; VAN DER ZON, J. M et al.Alimentary pharmacology & therapeutics. 1997, Vol 11, Num 2, pp 347-353, issn 0269-2813Article

Development and Validation of a Stability-Indicating High-Performance Liquid Chromatography Method for the Simultaneous Determination of Albuterol, Budesonide, and Ipratropium Bromide in Compounded Nebulizer SolutionsBLEWETT, Anthony J; VARMA, Deepti; GILLES, Tiffany et al.Journal of AOAC International. 2011, Vol 94, Num 1, pp 110-117, issn 1060-3271, 8 p.Article

Increased Transmucosal Uptake of E. coli K12 in Collagenous Colitis Persists After Budesonide TreatmentMÜNCH, Andreas; SÖDERHOLM, Johan D; OST, Ake et al.The American journal of gastroenterology. 2009, Vol 104, Num 3, pp 679-685, issn 0002-9270, 7 p.Article

Safety of Inhaled Budesonide : Clinical Manifestations of Systemic Corticosteroid-Related Adverse EffectsCHRISTENSSON, Camilla; THOREN, Anders; LINDBERG, Bengt et al.Drug safety. 2008, Vol 31, Num 11, pp 965-988, issn 0114-5916, 24 p.Article

Les colites microscopiques = Microscopic colitisFOMEGNE, G; GRUSELLE, P.Revue médicale de Bruxelles. 2005, Vol 26, Num 1, pp 43-47, issn 0035-3639, 5 p.Article

A randomized phase IIb trial of Pulmicort Turbuhaler (Budesonide) in people with dysplasia of the bronchial epitheliumLAM, Stephen; LERICHE, Jean C; GAZDAR, Adi et al.Clinical cancer research. 2004, Vol 10, Num 19, pp 6502-6511, issn 1078-0432, 10 p.Article

Bronchodilator effect of an inhaled combination therapy with salmeterol + fluticasone and formoterol + budesonide in patients with COPDCAZZOLA, M; SANTUS, P; DI MARCO, F et al.Respiratory medicine. 2003, Vol 97, Num 5, pp 453-457, issn 0954-6111, 5 p.Article

Systemic availability and pharmacokinetics of nebulised budesonide in preschool childrenAGERTOFT, L; ANDERSEN, A; WEIBULL, E et al.Archives of disease in childhood. 1999, Vol 80, Num 3, pp 241-247, issn 0003-9888Article

Daily or Intermittent Budesonide in Preschool Children with Recurrent WheezingZEIGER, Robert S; MAUGER, David; JACKSON, Daniel J et al.The New England journal of medicine. 2011, Vol 365, Num 21, pp 1990-2001, issn 0028-4793, 12 p.Article

Budesonide and Ciclesonide: Effect of Tissue Binding on Pulmonary Receptor Binding^sKAI WU; BLOMGREN, Anders L; EKHOLM, Kjell et al.Drug metabolism and disposition. 2009, Vol 37, Num 7, pp 1421-1426, issn 0090-9556, 6 p.Article

In Vitro Delivery of Budesonide From 30 Jet Nebulizer/Compressor Combinations Using Infant and Child Breathing PatternsBERG, Elna B; PICARD, Robert J.Respiratory care. 2009, Vol 54, Num 12, pp 1671-1678, issn 0020-1324, 8 p.Article

Oral budesonide in the treatment of chronic refractory pouchitisGIONCHETTI, P; RIZZELLO, F; POGGIOLI, G et al.Alimentary pharmacology & therapeutics. 2007, Vol 25, Num 10, pp 1231-1236, issn 0269-2813, 6 p.Article

Direct separation, identification and quantification of epimers 22R and 22S of budesonide by capillary gas chromatography on a short analytical column with Rtx®-5 stationary phaseKRZEK, Jan; CZEKAJ, Janusz S; RZESZUTKO, Włodzimierz et al.Journal of chromatography. B. 2004, Vol 803, Num 2, pp 191-200, issn 1570-0232, 10 p.Article

Increase in the specific surface area of budesonide during storage postmicronizationJOSHI, Vidya; DWIVEDI, Sarvajna; WARD, Gary H et al.Pharmaceutical research. 2002, Vol 19, Num 1, pp 7-12, issn 0724-8741Article

Assessment of the systemic effects of budesonide inhaled from Easyhaler® and from Turbuhaler® in healthy male volunteersHÄMÄLÄINEN, K. M; GRANANDER, M; TOIVANEN, P et al.Respiratory medicine. 2001, Vol 95, Num 11, pp 863-869, issn 0954-6111Article

Once-daily budesonide : 400 μg once daily is as effective as 200 μg twice daily in controlling childhood asthmaCAMPBELL, L. M; BODALIA, B; GOGBASHIAN, C. A et al.International journal of clinical practice (Esher). 1998, Vol 52, Num 4, pp 213-219, issn 1368-5031Article

Chromatographic and mass spectral characterization of budesonide and a series of structurally related corticosteroids using LC-MSSHUGUANG HOU; HINDLE, Michael; BYRON, Peter R et al.Journal of pharmaceutical and biomedical analysis. 2005, Vol 39, Num 1-2, pp 196-205, issn 0731-7085, 10 p.Article